文献速递肝病消化道肿瘤与早癌

肝细胞癌筛查连续性的概念模型:现状与研究议程

Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-09-19

肝细胞癌5年生存率低于20%,部分归因于筛查连续性中的失败,如高危患者筛查不足和HCC患者治疗不当。本文提出包含风险评估、筛查启动、筛查结果随访、诊断评估和治疗评估等步骤的概念模型,说明各步骤易出现延迟或失败并导致晚期诊断或生存不佳,比较HCC与乳腺癌和结直肠癌筛查流程以识别改进机会,并介绍美国国家癌症研究所成立转化肝癌联盟以改善HCC早期检测。

要点

  • 肝细胞癌5年生存率低于20%,部分归因于筛查连续性的失败。
  • 概念模型包含风险评估、筛查启动、结果随访、诊断评估和治疗评估等步骤。
  • 美国国家癌症研究所成立转化肝癌联盟,旨在改善HCC早期检测。

核心结论

  • 肝细胞癌预后差,部分归因于筛查连续性中的失败,如高危患者筛查不足和HCC患者治疗不当。
  • 概念模型说明筛查各步骤易出现延迟或失败,导致晚期诊断或生存不佳,患者、提供者和医疗系统层面的因素可促成这些失败。
  • 比较HCC与乳腺癌和结直肠癌筛查流程可识别改进机会。
  • 美国国家癌症研究所成立转化肝癌联盟,旨在改善HCC早期检测,针对筛查连续性失败的研究将有助于实现该目标。

研究设计与样本

  • 本文为概念模型阐述,提出肝细胞癌筛查连续性的多个离散步骤,并比较HCC与乳腺癌和结直肠癌筛查流程。

主要发现

  • 肝细胞癌5年生存率低于20%。
  • 筛查连续性各步骤易出现延迟或失败,导致晚期诊断或生存不佳。
  • 患者、提供者和医疗系统层面的因素可促成筛查失败。

关键数值与推荐

  • 肝细胞癌筛查连续性的概念模型包括风险评估、筛查启动、筛查结果随访、诊断评估和治疗评估等步骤。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatocellular carcinoma (HCC) continues to have a dismal prognosis, with 5-year survival below 20%. This poor prognosis can be in part attributed to failures along the cancer screening process continuum such as underuse of screening in at risk patients and appropriate treatments for patients with HCC. Better understanding these process failures, and how they compare to those seen in other cancer types, can help inform potential intervention targets and strategies to reduce HCC-related mortality. Herein, we outline a conceptual model with several discrete steps in the HCC screening process continuum including risk assessment, screening initiation, follow-up of screening results, diagnostic evaluation, and treatment evaluation. The conceptual model illustrates how each step in the screening process is prone to delays or failure, resulting in worse outcomes such as late stage diagnosis or poor survival, and how factors at the patient, provider, and health care system levels can contribute to these failures. We compare cancer screening processes for HCC with those employed in breast and colorectal cancer screening to identify opportunities for improvement. The Translational Liver Cancer consortium was recently established by the National Cancer Institute with the goal of improving early detection of HCC. Studies designed to address failures in the HCC screening process continuum will help accomplish this goal.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Singal AG, Lok AS, Feng Z, et al. Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda. Clin Gastroenterol Hepatol. 2020. PMID: 32961340. doi:10.1016/j.cgh.2020.09.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。